Abstract
Efficacy of Daratumumab Monotherapy on Bone Metabolism of Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results from the Phase 2 Rebuild Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have